CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $865,505 | -22.6% | 29,379 | -14.3% | 0.00% | 0.0% |
| Q2 2023 | $1,117,920 | -20.0% | 34,271 | -13.7% | 0.00% | -33.3% |
| Q1 2023 | $1,397,113 | -26.7% | 39,702 | -4.6% | 0.00% | -25.0% |
| Q4 2022 | $1,907,212 | -3.5% | 41,624 | +2.0% | 0.00% | -20.0% |
| Q3 2022 | $1,977,000 | +31.8% | 40,812 | +6.9% | 0.01% | +66.7% |
| Q2 2022 | $1,500,000 | +10.4% | 38,175 | +3.4% | 0.00% | 0.0% |
| Q1 2022 | $1,359,000 | -18.0% | 36,908 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $1,658,000 | +358.0% | 36,365 | +258.8% | 0.00% | +200.0% |
| Q3 2021 | $362,000 | +80.1% | 10,135 | 0.0% | 0.00% | – |
| Q2 2021 | $201,000 | -45.2% | 10,135 | -35.8% | 0.00% | -100.0% |
| Q1 2021 | $367,000 | +7.9% | 15,777 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $340,000 | -20.6% | 16,381 | -17.2% | 0.00% | 0.0% |
| Q3 2020 | $428,000 | -13.0% | 19,777 | -5.3% | 0.00% | 0.0% |
| Q2 2020 | $492,000 | +92.9% | 20,890 | -3.6% | 0.00% | – |
| Q1 2020 | $255,000 | +19.2% | 21,659 | +7.1% | 0.00% | – |
| Q4 2019 | $214,000 | +18.9% | 20,216 | +27.7% | 0.00% | – |
| Q3 2019 | $180,000 | +42.9% | 15,837 | +4.3% | 0.00% | – |
| Q2 2018 | $126,000 | +15.6% | 15,186 | 0.0% | 0.00% | – |
| Q1 2018 | $109,000 | -50.2% | 15,186 | -43.6% | 0.00% | – |
| Q4 2017 | $219,000 | -41.0% | 26,909 | +5.1% | 0.00% | – |
| Q3 2017 | $371,000 | +0.3% | 25,599 | -16.2% | 0.00% | – |
| Q2 2017 | $370,000 | +17.1% | 30,562 | +24.1% | 0.00% | – |
| Q1 2017 | $316,000 | +33.9% | 24,625 | +26.8% | 0.00% | – |
| Q4 2016 | $236,000 | +3.5% | 19,422 | -21.7% | 0.00% | – |
| Q3 2016 | $228,000 | +30.3% | 24,791 | +34.2% | 0.00% | – |
| Q2 2016 | $175,000 | +34.6% | 18,480 | 0.0% | 0.00% | – |
| Q1 2016 | $130,000 | -32.6% | 18,480 | 0.0% | 0.00% | – |
| Q4 2015 | $193,000 | +55.6% | 18,480 | 0.0% | 0.00% | – |
| Q3 2015 | $124,000 | +42.5% | 18,480 | +1.0% | 0.00% | – |
| Q2 2014 | $87,000 | -67.3% | 18,293 | -34.7% | 0.00% | -100.0% |
| Q1 2014 | $266,000 | +52.9% | 27,993 | +4.5% | 0.00% | 0.0% |
| Q4 2013 | $174,000 | -14.3% | 26,793 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $203,000 | – | 26,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |